Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ye-Jin Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurosurgery, Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Milk Proteins, Ischemic Stroke, Inflammation, Antigens, Surface. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Fund for Regenerative Medicine(KFRM).
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke is a neurological disorder resulting from localized brain injury due to focal cerebral ischemia, typically caused by the blockage of one or, in some cases, a few cerebral arteries. This arterial obstruction leads to hypoxia and energy failure, culminating in primary brain damage. Although reperfusion is critical to salvage viable tissue, it often intensifies injury through oxidative stress, inflammation, and cell death—a phenomenon called ischemia–reperfusion (I/R) injury. Milk fat globule-EGF factor 8 (MFG-E8), a multifunctional glycoprotein secreted by stem and immune cells, is a key regulator of inflammation and tissue repair. By modulating microglial activation, attenuating proinflammatory cytokine releases, and preserving neuronal integrity, MFG-E8 mitigates ischemia–reperfusion injury and emerges as a novel therapeutic target for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurosurgery, Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Department of Neurosurgery, Anam Hospital, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Department of Convergence Medicine, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
- Laboratory of Stem Cells and Tissue Regeneration, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.
ORCID-Profile: Jong-Hoon Kim, Dong-Hyuk Park
Förderung
- Korean Fund for Regenerative Medicine(KFRM)
Zitieren
APA
Han, Y. J., Lee, H. J., Geum, D. H., Kim, J. H., & Park, D. H. (2025). Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178708
Vancouver
Han YJ, Lee HJ, Geum DH, Kim JH, Park DH. Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178708
BibTeX
@article{Han2025,
author = {Han, Ye-Jin and Lee, Hye-Jin and Geum, Dong-Ho and Kim, Jong-Hoon and Park, Dong-Hyuk},
title = {Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178708}
}
EUVIMED